Unknown

Dataset Information

0

E-cadherin antagonizes transforming growth factor ?1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation.


ABSTRACT: Cadherins mediate cell-cell adhesion and catenin (ctn)-related signaling pathways. Liver fibrosis is accompanied by the loss of E-cadherin (ECAD), which promotes the process of epithelial-mesenchymal transition. Currently, no information is available about the inhibitory role of ECAD in hepatic stellate cell activation. Because of ECAD's potential for inhibiting the induction of transforming growth factor ?1 (TGF?1), we investigated whether ECAD overexpression prevents TGF?1 gene induction; we also examined what the molecular basis could be. Forced expression of ECAD decreased ?-smooth muscle actin and vimentin levels and caused decreases in the constitutive and inducible expression of the TGF?1 gene and its downstream genes. ECAD overexpression decreased Smad3 phosphorylation, weakly decreased Smad2 phosphorylation, and thus inhibited Smad reporter activity induced by either treatment with TGF?1 or Smad3 overexpression. Overexpression of a dominant negative mutant of ras homolog gene family A (RhoA) diminished the ability of TGF?1 to elicit its own gene induction. Consistently, transfection with a constitutively active mutant of RhoA reversed the inhibition of TGF?1-inducible or Smad3-inducible reporter activity by ECAD. Studies using the mutant constructs of ECAD revealed that the p120-ctn binding domain of ECAD was responsible for TGF?1 repression. Consistently, ECAD was capable of binding p120-ctn, which recruited RhoA; this prevented TGF?1 from increasing RhoA-mediated Smad3 phosphorylation. In the liver samples of patients with mild or severe fibrosis, ECAD expression reciprocally correlated with the severity of fibrosis.Our results demonstrate that ECAD inhibits Smad3/2 phosphorylation by recruiting RhoA to p120-ctn at the p120-ctn binding domain, whereas the loss of ECAD due to cadherin switching promotes the up-regulation of TGF?1 and its target genes, and facilitates liver fibrosis.

SUBMITTER: Cho IJ 

PROVIDER: S-EPMC3086490 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation.

Cho Il Je IJ   Kim Young Woo YW   Han Chang Yeob CY   Kim Eun Hyun EH   Anderson Richard A RA   Lee Young Sok YS   Lee Chang Ho CH   Hwang Se Jin SJ   Kim Sang Geon SG  

Hepatology (Baltimore, Md.) 20101001 6


<h4>Unlabelled</h4>Cadherins mediate cell-cell adhesion and catenin (ctn)-related signaling pathways. Liver fibrosis is accompanied by the loss of E-cadherin (ECAD), which promotes the process of epithelial-mesenchymal transition. Currently, no information is available about the inhibitory role of ECAD in hepatic stellate cell activation. Because of ECAD's potential for inhibiting the induction of transforming growth factor β1 (TGFβ1), we investigated whether ECAD overexpression prevents TGFβ1 g  ...[more]

Similar Datasets

| S-EPMC6912488 | biostudies-literature
| S-EPMC5192182 | biostudies-literature
| S-EPMC6605627 | biostudies-literature
| S-EPMC5760593 | biostudies-literature
| S-EPMC6270946 | biostudies-literature
| S-EPMC6021006 | biostudies-literature
| S-EPMC4766441 | biostudies-literature
| S-EPMC4627336 | biostudies-literature
| S-EPMC9647113 | biostudies-literature
| S-EPMC7243025 | biostudies-literature